US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 2.350
  • -0.050-2.08%
Close Mar 28 16:00 ET
  • 2.350
  • 0.0000.00%
Post 20:01 ET
150.47MMarket Cap-1.78P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-111.48%-70.76M
-133.49%-21.82M
-166.80%-24.55M
-89.93%-13.99M
-37.88%-10.41M
-21.36%-33.46M
-40.03%-9.34M
-56.52%-9.2M
1.62%-7.37M
-0.24%-7.55M
Net income from continuing operations
-118.15%-80.6M
-121.84%-28.82M
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
Depreciation and amortization
2.25%318K
-4.94%77K
-2.63%74K
14.47%87K
2.56%80K
-2.20%311K
3.85%81K
-1.30%76K
-6.17%76K
-4.88%78K
Other non cash items
-130.49%-189K
-137.50%-57K
-557.14%-46K
-59.26%-43K
-79.17%-43K
-78.26%-82K
-33.33%-24K
46.15%-7K
-170.00%-27K
-380.00%-24K
Change In working capital
345.92%6.18M
149.61%5.76M
-537.85%-9.32M
765.91%7.07M
215.90%2.66M
-250.45%-2.51M
31.29%2.31M
-288.52%-1.46M
-88.97%-1.06M
-660.26%-2.3M
-Change in prepaid assets
-694.84%-8.47M
-373.46%-2.3M
-632.52%-4.48M
-316.86%-1.41M
-173.32%-272K
-422.06%-1.07M
-515.38%-486K
-0.66%-612K
-168.28%-338K
278.37%371K
-Change in payables and accrued expense
1,122.95%14.58M
185.10%8.04M
-464.73%-4.85M
1,285.25%8.44M
210.44%2.95M
-177.36%-1.43M
72.31%2.82M
-162.38%-859K
33.83%-712K
-2,713.68%-2.67M
-Change in other current assets
400.00%63K
200.00%25K
50.00%15K
450.00%42K
-416.67%-19K
-167.74%-21K
-600.00%-25K
66.67%10K
-163.16%-12K
500.00%6K
Cash from discontinued investing activities
Operating cash flow
-111.48%-70.76M
-133.49%-21.82M
-166.80%-24.55M
-89.93%-13.99M
-37.88%-10.41M
-21.36%-33.46M
-40.03%-9.34M
-56.52%-9.2M
1.62%-7.37M
-0.24%-7.55M
Investing cash flow
Cash flow from continuing investing activities
-356.01%-85.39M
830.20%19.2M
158.74%27.27M
-545.38%-63.49M
-174.11%-68.36M
136.67%33.35M
94.97%-2.63M
-1,272.04%-46.43M
72.16%-9.84M
92.25M
Net PPE purchase and sale
-214.02%-515K
-9.15%-179K
---62K
----
----
-64.00%-164K
---164K
--0
----
----
Net investment purchase and sale
-353.22%-84.87M
886.04%19.38M
158.87%27.33M
-542.59%-63.22M
-174.11%-68.36M
136.89%33.52M
95.28%-2.47M
-1,272.04%-46.43M
72.08%-9.84M
--92.25M
Cash from discontinued investing activities
Investing cash flow
-356.01%-85.39M
830.20%19.2M
158.74%27.27M
-545.38%-63.49M
-174.11%-68.36M
136.67%33.35M
94.97%-2.63M
-1,272.04%-46.43M
72.16%-9.84M
--92.25M
Financing cash flow
Cash flow from continuing financing activities
539,510.00%161.88M
36K
0.00%30K
-334K
162.15M
-99.96%30K
0
30K
0
0
Net common stock issuance
--161.81M
--0
--0
---345K
--162.15M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
156.67%77K
--36K
0.00%30K
----
----
--30K
--0
--30K
----
----
Cash from discontinued financing activities
Financing cash flow
539,510.00%161.88M
--36K
0.00%30K
---334K
--162.15M
-99.96%30K
--0
-99.96%30K
--0
--0
Net cash flow
Beginning cash position
-0.27%28.09M
-9.12%36.41M
-64.82%33.65M
-1.24%111.46M
-0.27%28.09M
-60.57%28.16M
-54.16%40.06M
353.90%95.66M
76.62%112.86M
-60.57%28.16M
Current changes in cash
7,647.37%5.74M
78.43%-2.58M
104.96%2.76M
-352.33%-77.81M
-1.56%83.38M
99.82%-76K
79.78%-11.97M
-183.85%-55.6M
59.83%-17.2M
1,224.37%84.7M
End cash Position
20.42%33.82M
20.42%33.82M
-9.12%36.41M
-64.82%33.65M
-1.24%111.46M
-0.27%28.09M
-0.27%28.09M
-54.16%40.06M
353.90%95.66M
76.62%112.86M
Free cash flow
-111.98%-71.28M
-131.35%-21.99M
-167.48%-24.61M
-93.65%-14.26M
-37.88%-10.41M
-21.52%-33.62M
-42.49%-9.51M
-56.52%-9.2M
2.91%-7.37M
-0.24%-7.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -111.48%-70.76M-133.49%-21.82M-166.80%-24.55M-89.93%-13.99M-37.88%-10.41M-21.36%-33.46M-40.03%-9.34M-56.52%-9.2M1.62%-7.37M-0.24%-7.55M
Net income from continuing operations -118.15%-80.6M-121.84%-28.82M-71.00%-15.5M-158.51%-21.63M-124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M
Depreciation and amortization 2.25%318K-4.94%77K-2.63%74K14.47%87K2.56%80K-2.20%311K3.85%81K-1.30%76K-6.17%76K-4.88%78K
Other non cash items -130.49%-189K-137.50%-57K-557.14%-46K-59.26%-43K-79.17%-43K-78.26%-82K-33.33%-24K46.15%-7K-170.00%-27K-380.00%-24K
Change In working capital 345.92%6.18M149.61%5.76M-537.85%-9.32M765.91%7.07M215.90%2.66M-250.45%-2.51M31.29%2.31M-288.52%-1.46M-88.97%-1.06M-660.26%-2.3M
-Change in prepaid assets -694.84%-8.47M-373.46%-2.3M-632.52%-4.48M-316.86%-1.41M-173.32%-272K-422.06%-1.07M-515.38%-486K-0.66%-612K-168.28%-338K278.37%371K
-Change in payables and accrued expense 1,122.95%14.58M185.10%8.04M-464.73%-4.85M1,285.25%8.44M210.44%2.95M-177.36%-1.43M72.31%2.82M-162.38%-859K33.83%-712K-2,713.68%-2.67M
-Change in other current assets 400.00%63K200.00%25K50.00%15K450.00%42K-416.67%-19K-167.74%-21K-600.00%-25K66.67%10K-163.16%-12K500.00%6K
Cash from discontinued investing activities
Operating cash flow -111.48%-70.76M-133.49%-21.82M-166.80%-24.55M-89.93%-13.99M-37.88%-10.41M-21.36%-33.46M-40.03%-9.34M-56.52%-9.2M1.62%-7.37M-0.24%-7.55M
Investing cash flow
Cash flow from continuing investing activities -356.01%-85.39M830.20%19.2M158.74%27.27M-545.38%-63.49M-174.11%-68.36M136.67%33.35M94.97%-2.63M-1,272.04%-46.43M72.16%-9.84M92.25M
Net PPE purchase and sale -214.02%-515K-9.15%-179K---62K---------64.00%-164K---164K--0--------
Net investment purchase and sale -353.22%-84.87M886.04%19.38M158.87%27.33M-542.59%-63.22M-174.11%-68.36M136.89%33.52M95.28%-2.47M-1,272.04%-46.43M72.08%-9.84M--92.25M
Cash from discontinued investing activities
Investing cash flow -356.01%-85.39M830.20%19.2M158.74%27.27M-545.38%-63.49M-174.11%-68.36M136.67%33.35M94.97%-2.63M-1,272.04%-46.43M72.16%-9.84M--92.25M
Financing cash flow
Cash flow from continuing financing activities 539,510.00%161.88M36K0.00%30K-334K162.15M-99.96%30K030K00
Net common stock issuance --161.81M--0--0---345K--162.15M--0--0--0--0--0
Proceeds from stock option exercised by employees 156.67%77K--36K0.00%30K----------30K--0--30K--------
Cash from discontinued financing activities
Financing cash flow 539,510.00%161.88M--36K0.00%30K---334K--162.15M-99.96%30K--0-99.96%30K--0--0
Net cash flow
Beginning cash position -0.27%28.09M-9.12%36.41M-64.82%33.65M-1.24%111.46M-0.27%28.09M-60.57%28.16M-54.16%40.06M353.90%95.66M76.62%112.86M-60.57%28.16M
Current changes in cash 7,647.37%5.74M78.43%-2.58M104.96%2.76M-352.33%-77.81M-1.56%83.38M99.82%-76K79.78%-11.97M-183.85%-55.6M59.83%-17.2M1,224.37%84.7M
End cash Position 20.42%33.82M20.42%33.82M-9.12%36.41M-64.82%33.65M-1.24%111.46M-0.27%28.09M-0.27%28.09M-54.16%40.06M353.90%95.66M76.62%112.86M
Free cash flow -111.98%-71.28M-131.35%-21.99M-167.48%-24.61M-93.65%-14.26M-37.88%-10.41M-21.52%-33.62M-42.49%-9.51M-56.52%-9.2M2.91%-7.37M-0.24%-7.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+10.49%
eBay
EBAY
+0.52%
Collegium Pharmaceutical
COLL
+0.51%
Dorian LPG
LPG
+0.31%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%

Unlock the Full List